You Have a Great Story
WE KNOW HOW TO TELL IT
Bioscribe was founded in 1997 in the San Francisco Bay Area to support the area's growing biotechnology industry. For 20 years, we have been a leading boutique PR agency working with companies that powered the Human Genome Project and cutting-edge start-ups that are innovating to unlock its value. We've helped launch first, second and third-generation DNA sequencing systems, molecular biology lab tools and automation solutions, bioinformatics software, single cell analysis solutions, molecular diagnostics, DNA forensics systems, next-generation biotherapeutics, and vaccines.
Our senior PR consultants and writers bring decades of experience and expertise in the biotech, molecular diagnostics, pharma, and life science research markets. In addition to previous large PR agency experience, some of our team members have built and run in-house communications teams, and have covered the industry as journalists and editors of leading publications.
If you need help telling your great stories, we'd love to talk to you. Contact us at
info [@] bioscribe.com.
AREAS OF EXPERTISE
We help our clients define their messaging and positioning, identify publicity opportunities, manage day-to-day corporate and product news flow, and get media coverage.
Areas of expertise include:
To submit RFPs, or to learn more about what we do, please contact us at info [@] bioscribe.com.
Media Strategy & Relations
Positioning & Messaging, Media Audits, Media Lists, Editorial Calendars, Journalist Outreach, Interview Preparation & Facilitation, Media Training, Coverage Monitoring, Social Media
Editorial Strategy & Content Marketing
Editorial Planning, Customer Profiles, Content Development & Editing, Bylined Articles, White Papers, Case Studies, Marketing Collateral, Social Media & Website Content
Messaging & Positioning, Publicity Plans, Press Releases, News Distribution, Media Events, Product Placement, Tradeshow Support
Blog & Newsletter Content
Editorial Calendar Planning, Content Development, Managing Approval Process, Posting Blogs
Thought Leadership & Industry Recognition
Presentation/Talk Development, Op-Eds, Speaking Opportunities, Awards Programs
Corporate Positioning & Branding, Financing Milestones, Mergers & Expansions, Organizational Communicatons, Issues Management
It's The Companies We Keep
Our clients include innovative start-ups powering the DNA revolution, therapeutics companies with the next potential breakthrough for cancer, innovative life science technology companies expanding markets, and financiers of healthcare innovation.
Novel advanced imaging agents for the early diagnosis of neurodegenerative diseases
Alzeca is focused on developing novel, proprietary, targeted MRI imaging agents for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company’s proprietary technology is based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear.
Intercepting cancer's survival mechanisms
Aravive is developing novel cancer therapeutics that spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways. The company's primary therapeutics focus is the GAS6-AXL pathway, whereby they can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread, and acquire therapeutic resistance.
Actionable strategies for life sciences
Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.
Developing the next class of antiviral agents for HIV
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. Their lead product candidate, Pro140, is the first self-administered antibody in late-stage clinical trials and works by blocking HIV from entering cells.
NGS-based meta-genomics tests for infectious diseases
San Francisco, CA
IDbyDNA's mission is to identify any microbe from any sample, anywhere in the world. A global leader in metagenomics, microbial genetics and data analytics, the company leverages advanced genome science and cutting-edge search technologies we are leading the transformation to bring precision medicine to infectious disease diagnosis.
The future of science is sound
Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.
Breakthrough solutions to improve health and advance science
Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.
MedCision is changing vital preclinical and clinical processes
San Rafael, CA
MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes.
Analytical detection devices for the next generation of rapid point-of-care diagnostics
Founded by physicists from the University of California-Berkeley and Lawrence Berkeley National Laboratory, Nanōmix is developing the next generation of mobile, point-of-care medical diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. .
Mission-driven company aiming to transform the way cancer is treated
San Francisco, CA
Notable is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the company is discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance.
Investment bankers for middle market growth companies in life sciences
Wellesley, Mass and Reston, VA
Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.
Third-generation DNA sequencing for complex genomics projects
Menlo Park, CA
Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.
Clinical-stage biopharmaceutical company developing peptide-based targeted therapies for gastrointestinal diseases
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) to address significant unmet medical needs. Its primary focus is on developing first-in-class oral peptide drugs that specifically target biological pathways involved in gastrointestinal diseases.
The global leader in applications to quickly analyze and interpret genomic data
Redwood City, CA
Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.
DNA size selection for next-gen sequencing
Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.
Health information company merging big data analytics with clinical diagnostics
Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics.
Restoring clarity of thought
Grand Rapids, MI
Tetra Discovery Partners is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, traumatic brain injury, major depression and schizophrenia. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.
Developers of broad-spectrum anti-viral drugs that target the lipid envelope
TSG Therapeutics is a preclinical-stage biopharmaceutical company on a mission to eliminate viral infectious disease. TSG has designed a novel class of broad-spectrum antiviral drugs that are adaptable, scalable, and therapeutically effective against a wide range of emerging and re-emerging viruses, such as Zika and Dengue.
Developers of hand-held, battery operated molecular detection systems
Santa Cruz, CA
Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.
Some of our past clients include:
Allakos, Association for Molecular Pathology, Applied Biosystems, BD Biosciences, Benchling, Biotique Systems, Cellular Resarch (purchased by BD) Chiron Corporation, Connetics Corporation, Cynvenio Biosystems, DNAnexus, DoubleTwist, Eos, Eurofins Genomics, GE healthymagination, Gen9, Genentech, GenoSpectra, IntegenX, Invitrogen, Microsoft Health Solutions, Medtronic, Mohr Davidow Ventures, NanoString Technologies, Nektar, NIST: Multiplexed Biomolecular Science Group, Omicia, Osel, PAG, PaxVax, Personalis, RainDance Technologies, StationX, Varian Medical Systems, VitaPath Genetics, Zyomyx
President & CEO
Nicole founded Bioscribe in 1997 in San Francisco to meet the communications needs of the emerging biotech industry. She has more than 20 years experience providing PR counsel to Fortune 500 companies, small start-ups, and non-profit associations in this industry.
Senior Vice President
Joan is an industry veteran who started her career at Genentech in regulatory affairs and then became a biotech journalist before switching to the other side of the desk to provide strategic communications counsel to biotechnology companies, including efforts to support financing and corporate partnering initiatives.
Vice President, Editorial Strategy
OUR CLIENTS IN THE NEWS
Here is a sample of some of the stories we are helping to tell...
We are a small group of senior, self-directed professionals passionate about helping clients communicate stories about life science innovations. We are currently recruiting PR counselors, media relations pros, and scientific marketing content writers and MarCom experts who have experience working on biotech accounts. Please send a copy of your resume to us (info [at] bioscribe [dot] com). If it looks like a great match, we'll be in touch. Thanks!